A detailed history of Lee Ainslie (Maverick Capital LTD) transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Maverick Capital LTD holds 68,779 shares of TEVA stock, worth $1.17 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
68,779
Previous 65,483 5.03%
Holding current value
$1.17 Million
Previous $1.06 Million 16.45%
% of portfolio
0.03%
Previous 0.02%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$15.81 - $18.96 $52,109 - $62,492
3,296 Added 5.03%
68,779 $1.24 Million
Q2 2024

Aug 14, 2024

BUY
$12.78 - $17.4 $101,447 - $138,121
7,938 Added 13.79%
65,483 $1.06 Million
Q1 2024

May 15, 2024

SELL
$10.67 - $14.43 $58,706 - $79,393
-5,502 Reduced 8.73%
57,545 $811,000
Q4 2023

Feb 14, 2024

BUY
$8.12 - $10.63 $243,129 - $318,283
29,942 Added 90.45%
63,047 $658,000
Q3 2023

Nov 14, 2023

SELL
$7.48 - $10.7 $130,772 - $187,068
-17,483 Reduced 34.56%
33,105 $337,000
Q2 2023

Aug 14, 2023

SELL
$7.2 - $9.47 $16,394 - $21,563
-2,277 Reduced 4.31%
50,588 $380,000
Q1 2023

May 15, 2023

BUY
$8.36 - $11.37 $179,037 - $243,499
21,416 Added 68.1%
52,865 $467,000
Q4 2022

Feb 14, 2023

BUY
$7.95 - $9.48 $250,019 - $298,136
31,449 New
31,449 $286,000
Q3 2021

Nov 15, 2021

SELL
$8.38 - $10.18 $376,086 - $456,868
-44,879 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$9.9 - $11.56 $1.1 Million - $1.28 Million
-110,962 Reduced 71.2%
44,879 $444,000
Q1 2021

May 17, 2021

BUY
$10.34 - $12.81 $1.15 Million - $1.42 Million
111,167 Added 248.84%
155,841 $1.8 Million
Q4 2020

Feb 16, 2021

SELL
$8.61 - $11.04 $693,130 - $888,753
-80,503 Reduced 64.31%
44,674 $431,000
Q3 2020

Nov 16, 2020

BUY
$8.57 - $12.69 $1.07 Million - $1.59 Million
125,177 New
125,177 $1.13 Million
Q1 2020

May 15, 2020

SELL
$6.69 - $13.45 $3.09 Million - $6.21 Million
-461,715 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$6.53 - $10.72 $1.3 Million - $2.14 Million
-199,500 Reduced 30.17%
461,715 $4.53 Million
Q3 2019

Nov 14, 2019

BUY
$6.16 - $9.6 $4.07 Million - $6.35 Million
661,215 New
661,215 $4.55 Million
Q2 2019

Aug 14, 2019

SELL
$8.12 - $15.72 $767,583 - $1.49 Million
-94,530 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$15.58 - $20.01 $2.29 Million - $2.94 Million
-146,690 Reduced 60.81%
94,530 $1.48 Million
Q4 2018

Feb 14, 2019

BUY
$14.59 - $23.84 $3.52 Million - $5.75 Million
241,220 New
241,220 $3.72 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $18.9B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track Lee Ainslie's Portfolio

Track Lee Ainslie Portfolio

Follow Lee Ainslie (Maverick Capital LTD) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.